Antibody persistence in mothers one year after pneumococcal immunization in pregnancy

Vaccine

Volumn 30, Issue 34, 2012, Pages 5063-5066

  Schlaudecker, Elizabeth P ^a   Steinhoff, Mark C ^a   Omer, Saad B ^b   Roy, Eliza ^c   Arifeen, Shams E ^c   Dodd, Caitlin N ^a   Altaye, Mekibib ^a   Raqib, Rubhana ^c   Breiman, Robert F ^d   Zaman, K ^c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY   (United States)

^c INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antibody titers; Maternal immunization; Pneumococcal vaccine

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; MATERNAL ANTIBODY; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNIZATION; INFLUENZA VACCINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROTYPE; THIRD TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BANGLADESH; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLUENZA VACCINES; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREGNANCY; PROSPECTIVE STUDIES; TIME FACTORS; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 84863775326     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.06.003     Document Type: Article

References (15)

1. WHO Pneumococcal conjugate vaccine for childhood immunization-WHO position paper. Wkly Epidemiol Rec 2007, 82:93-104.
2. Enwere G., Biney E., Cheung Y.B., Zaman S.M., Okoko B., Oluwalana C., et al. Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia. Pediatr Infect Dis J 2006, 25:700-705.
3. Traore Y., Tameklo T.A., Njanpop-Lafourcade B.M., Lourd M., Yaro S., Niamba D., et al. Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo. Clin Infect Dis 2009, 48(Suppl 2):S181-S189.
4. Mudhune S., Wamae M. Report on invasive disease and meningitis due to Haemophilus influenzae and Streptococcus pneumonia from the Network for Surveillance of Pneumococcal Disease in the East African Region. Clin Infect Dis 2009, 48(Suppl 2):S147-S152.
5. Shahid N.S., Steinhoff M.C., Hoque S.S., Begum T., Thompson C., Siber G.R. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet 1995, 346:1252-1257.
6. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008, 359:1555-1564.
7. Francis J.P., Richmond P.C., Pomat W.S., Michael A., Keno H., Phuanukoonnon S., et al. Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants. Clin Vaccine Immunol 2009, 16:1633-1638.
8. Quiambao B.P., Nohynek H.M., Kayhty H., Ollgren J.P., Gozum L.S., Gepanayao C.P., et al. Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies. Vaccine 2007, 25:4470-4477.
9. Lopes C.R., Berezin E.N., Ching T.H., Canuto Jde S., Costa V.O., Klering E.M. Ineffectiveness for infants of immunization of mothers with pneumococcal capsular polysaccharide vaccine during pregnancy. Braz J Infect Dis 2009, 13:104-106.
10. Munoz F.M., Englund J.A., Cheesman C.C., Maccato M.L., Pinell P.M., Nahm M.H., et al. Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine 2001, 20:826-837.
11. Santosham M., Englund J.A., McInnes P., Croll J., Thompson C.M., Croll L., et al. Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants. Pediatr Infect Dis J 2001, 20:931-940.
12. Whaley M.J., Rose C., Martinez J., Laher G., Sammons D.L., Smith J.P., et al. Interlaboratory comparison of three multiplexed bead-based immunoassays for measuring serum antibodies to pneumococcal polysaccharides. Clin Vaccine Immunol 2010, 17:862-869.
13. Siber G.R., Chang I., Baker S., Fernsten P., O'Brien K.L., Santosham M., et al. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine 2007, 25:3816-3826.
14. Musher D.M., Manof S.B., Liss C., McFetridge R.D., Marchese R.D., Bushnell B., et al. Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults. J Infect Dis 2010, 201:516-524.
15. Goldblatt D., Hussain M., Andrews N., Ashton L., Virta C., Melegaro A., et al. Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis 2005, 192:387-393.